MedPath

One Dose Versus Three Weekly Doses of Benzathine Penicillin G for Patients With Early Syphilis

Phase 4
Conditions
Syphilis
Interventions
Drug: Benzathine Penicillin G
Registration Number
NCT02857959
Lead Sponsor
Jun Li
Brief Summary

The purpose of this study is to observe the serological response to 1 or 3 weekly doses of benzathine penicillin G in patients with early syphilis.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  1. Persons with confirmed early symptomatic syphilis (primary or secondary) or high-titer latent syphilis
  2. A rapid plasma reagin (RPR) test was positive, with a titer were 1:4 or higher. In addition, Treponema pallidum particle agglutination assay and/or fluorescent treponemal antibody absorption test were reactive.
Exclusion Criteria

1.Patients who were pregnancy, known allergy to penicillin, use of antibiotics active against syphilis during the preceding six months for symptomatic cases or during the preceding two years for asymptomatic cases, and concurrent illnesses requiring treatment with antibiotics effective against syphilis. 2. if RPR titers were found to be 1:4 or less or the T. pallidum particle agglutination test was nonreactive, participants were retrospectively excluded from the trial unless primary syphilis was confirmed by the finding of T. pallidum in ulcer exudates on direct immunofluorescence

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
single dose benzathine penicillin G.Benzathine Penicillin Gsingle dose benzathine penicillin G.
three doses of benzathine penicillin G.Benzathine Penicillin Gthree doses of benzathine penicillin G.
Primary Outcome Measures
NameTimeMethod
Rapid plasma reagin titersup to 9 months after treatment
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Dermatology and Venereology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath